Historical record - last NADAC effective date: 2/22/2017
Product Information
PEPCID 40 MG TABLET is a generic product labeled by Bausch Health US LLC, priced at $0.0856 per EA under NDC 00187444010. Its NADAC has been published 11 times since Dec 14, 2016.
FDA first approved this application on Apr 16, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Bausch Health US LLCNDC
00187444010
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/22/2017
Active Ingredients
FAMOTIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA075805FDA Approved
4/16/2001
TE Code
AB
On Market Since
4/16/2001
Pharmacological Classes
Price Statistics
The NADAC for PEPCID 40 MG TABLET has been published 11 times since Dec 14, 2016, and over the history we have for it it has risen 11.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0856 per EA |
|---|---|
| All-time high | $0.0856 (Feb 22, 2017) |
| All-time low | $0.0770 (Dec 14, 2016) |
| Median price | $0.0802 |
| Average price | $0.0806 |
| Largest weekly change | +6.8% (Feb 22, 2017) |
| Weeks tracked | 11 |
| Tracking since | Dec 14, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+11.2%
Last surveyed Feb 22, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 44% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch Health US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
famotidine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PEPCID 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PEPCID 40 MG TABLET, manufactured by Bausch Health US LLC, is $0.0856 per EA (NDC 00187444010), effective Feb 22, 2017.
How has the price of PEPCID 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for PEPCID 40 MG TABLET has risen 11.2%. It has been tracked across 11 weekly CMS publications since Dec 14, 2016.
What are the highest and lowest recorded NADAC prices for PEPCID 40 MG TABLET?
Since Dec 14, 2016, the NADAC for PEPCID 40 MG TABLET has ranged from a low of $0.0770 (Dec 14, 2016) to a high of $0.0856 (Feb 22, 2017), with a median of $0.0802 per EA.
Are there cheaper alternatives to PEPCID 40 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FAMOTIDINE 40 MG TABLET, is $0.0483 per EA — about 44% below PEPCID 40 MG TABLET.
Who manufactures PEPCID 40 MG TABLET?
PEPCID 40 MG TABLET (NDC 00187444010) is labeled by Bausch Health US LLC, and CMS classifies it as a generic product.